PGEN - Company ID 0001356090
The table below shows PRECIGEN, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $23.25M | - | - | $1.34M | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $5.64M | - | - | $10.48M | - | - |
| SG&A |
PRECIGEN, INC. reported annual revenue of $9.68M for fiscal year 2025. That is up 146.7% from $3.92M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $190.93M (FY 2016) to $9.68M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $21.05M |
| - |
| - |
| $12.36M |
| - |
| - |
| Operating income | -$5.99M | - | - | -$22.60M | - | - |
| Income tax | $0.00 | $0.00 | $3.00K | $0.00 | $12.00K | -$1.69M |
| Net income | -$7.93M | -$146.34M | -$26.64M | -$54.15M | -$23.98M | -$58.79M |
| EPS (diluted) | -$0.02 | -$1.06 | -$0.09 | -$0.18 | -$0.09 | -$0.23 |